Succinic Acid

Succinic Acid

SCHEMBL24696

O=C(O)CCC(=O)O.O=C(O)CCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 1.00
EGLN1 Q9GZT9 3/20 1.00
ALKBH5 Q6P6C2 1/20 1.00
SUCNR1 Q9BXA5 1/20 1.00
SLC22A6 Q4U2R8 1/20 0.67
SLC15A2 Q16348 1/20 0.64
MAPK1 P28482 1/20 0.64
SLC13A3 Q8WWT9 1/20 0.64
OR51E2 Q9H255 1/20 0.64
TSHR P16473 3/20 0.61
NFKB1 P19838 1/20 0.61
PMP22 Q01453 1/20 0.61
HDAC3 O15379 2/20 0.57
HDAC1 Q13547 2/20 0.57
HDAC2 Q92769 2/20 0.57
HDAC8 Q9BY41 2/20 0.57
FFAR3 O14843 1/20 0.57
KDM4E B2RXH2 2/20 0.56
KDM5C P41229 2/20 0.56
PHF8 Q9UPP1 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL8992010 1.00 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL3799615 1.00
Succinic Acid SCHEMBL1331252 1.00
Succinic Acid SCHEMBL829 1.00
Succinic Acid SCHEMBL4269135 1.00 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL29808469 1.00
Succinic Acid SCHEMBL4269130 1.00 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL1331200 1.00
Succinic Acid SCHEMBL21867134 1.00 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1SLC22A6
Succinic Acid SCHEMBL28176099 1.00 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025118084-A1 EARLY BREAST CANCER DETECTION USING BLOOD-BASED METABOLOMIC PROFILING BIOMARK CANCER SYSTEMS INC. (CA) 2025-06-12 WO claimed
US-11753635-B2 Methods and systems and related compositions for mixtures separation with a solid matrix CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-09-12 US claimed
CN-114505616-A Solder paste for microwave welding and preparation method and welding method thereof 深圳市汉尔信电子科技有限公司 2022-05-17 CN claimed
US-20220049242-A1 METHODS AND SYSTEMS AND RELATED COMPOSITIONS FOR MIXTURES SEPARATION WITH A SOLID MATRIX CALIFORNIA INSTITUTE OF TECHNOLOGY 2022-02-17 US claimed
CN-213176777-U Wear-resistant automobile sealing element 温州万泰橡塑股份有限公司 2021-05-11 CN claimed
CN-110777386-B Multifunctional copper cleaning agent and preparation method thereof 江南大学 2020-09-04 CN claimed
CN-110777386-A Multifunctional copper cleaning agent and preparation method thereof 江南大学 2020-02-11 CN claimed
CN-109970706-A A kind of preparation and refining methd of amber love song Ge Lieting A crystal form 徐州万邦金桥制药有限公司 2019-07-05 CN claimed
CN-108530743-A A kind of plastic formula 徐州通用高新磁电有限公司 2018-09-14 CN claimed
CN-103405753-B Stable insulin secretion accelerating peptide liquid drugs injection pharmaceutical composition Shanghai Renhui biological pharmaceutical Co., Ltd. (CN) 2016-05-11 CN claimed
CN-101750920-B Toner KAO CORP 2013-06-19 CN claimed
CN-103131687-A Polyethylene glycol covalent modification lysostaphin and prepared method and application thereof HANGZHOU LION BIOTECHNOLOGY CO LTD 2013-06-05 CN claimed
US-20110136989-A1 POLYETHERAMIDE COMPOSITIONS AKZO NOBEL N.V. (NL) 2011-06-09 US claimed
WO-2011058232-A1 NUTRIGENETIC BIOMARKERS FOR OBESITY AND TYPE 2 DIABETES MAS-METABOLIC ANALYTICAL SERVICES OY (FI) 2011-05-19 WO claimed
EP-2284540-A1 Method of diagnosing organ failure BIOCRATES Life Sciences AG (AT) 2011-02-16 EP claimed
WO-2011012553-A1 METHOD FOR PREDICTING THE LIKELIHOOD OF AN ONSET OF AN INFLAMMATION ASSOCIATED ORGAN FAILURE BIOCRATES LIFE SCIENCES AG (AT) 2011-02-03 WO claimed
WO-2011000753-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES LIFE SCIENCES AG (AT) 2011-01-06 WO claimed
EP-2270699-A1 Method for normalization in metabolomics analysis methods with endogenous reference metabolites BIOCRATES Life Sciences AG (AT) 2011-01-05 EP claimed
EP-1068219-B1 ACYLATED BETULIN AND DIHYDROBETULIN DERIVATIVES, PREPARATION THEREOF AND USE THEREOF UNIV NORTH CAROLINA (US) 2006-12-20 EP claimed
WO-2004089357-A2 ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2004-10-21 WO claimed